← Back to Search

Behavioral Intervention

Personality-Based Therapy for Borderline Personality Disorder

N/A
Recruiting
Led By Shannon Sauer-Zavala, PhD
Research Sponsored by Shannon E. Sauer-Zavala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly up to 14 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial assesses the effectiveness of a treatment module for borderline personality disorder over a 6 week period and 4 week follow-up.

Who is the study for?
This trial is for English-speaking individuals diagnosed with Borderline Personality Disorder. It's not suitable for those who have other psychological conditions needing different treatments, are currently in psychotherapy, have substance use disorders, or whose medication use isn't stable.
What is being tested?
The study tests a new therapy specifically designed for personality changes in people with Borderline Personality Disorder. Participants will first be observed without treatment and then receive six weekly sessions of the therapy to see its effects.
What are the potential side effects?
Since this trial involves therapy sessions rather than medication, typical medical side effects aren't expected. However, discussing emotional topics may cause temporary discomfort or distress.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly up to 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and weekly up to 14 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in clinician-rated borderline personality disorder symptoms
Change in patient-reported borderline personality disorder symptoms

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Personality-based treatment 4 week baselineExperimental Treatment1 Intervention
Participants will receive treatment tailored to 1 of 3 personality dimensions after a 4 week baseline assessment
Group II: Personality-based treatment 2 week baselineExperimental Treatment1 Intervention
Participants will receive treatment tailored to 1 of 3 personality dimensions after a 2 week baseline assessment

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,918 Previous Clinical Trials
2,739,886 Total Patients Enrolled
13 Trials studying Borderline Personality Disorder
2,051 Patients Enrolled for Borderline Personality Disorder
American Psychological FoundationOTHER
18 Previous Clinical Trials
1,943 Total Patients Enrolled
Shannon E. Sauer-ZavalaLead Sponsor
4 Previous Clinical Trials
366 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
100 Patients Enrolled for Borderline Personality Disorder
~11 spots leftby Aug 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top